Repligen
RGEN
#2045
Rank
HK$72.29 B
Marketcap
HK$1,284
Share price
-0.47%
Change (1 day)
15.97%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of September 2025 : HK$5.36 Billion

According to Repligen 's latest financial reports the company's total debt is HK$5.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.32 B-4.17%
2023-12-31HK$5.55 B68.22%
2022-12-31HK$3.30 B15.78%
2021-12-31HK$2.85 B33.69%
2020-12-31HK$2.13 B4.11%
2019-12-31HK$2.05 B153.05%
2018-12-31HK$0.81 B4.51%
2017-12-31HK$0.77 B4.96%
2016-12-31HK$0.73 B
2005-03-31HK$0.93 M40.18%
2004-03-31HK$0.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novavax
NVAX
HK$1.95 B-63.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.70 B-12.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.33 B-37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$162.21 B 2,924.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$277.74 B 5,079.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.32 B 7,309.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$473.66 B 8,733.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$3.07 B-42.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.19 B-96.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$20.46 B 281.59%๐Ÿ‡บ๐Ÿ‡ธ USA